+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Early Phase 1
Age: 18Years - 59Years
All Genders
Healthy Volunteers
ID07290205

Study of Brain Activity and Memory During Remimazolam Sedation Using MRI in Adults Aged 18 to 59

Led by Keith M Vogt · Updated on 2026-04-02

60

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of remimazolam on brain function, cognition, and connectivity using functional MRI. This single-arm early phase study focuses on brain activity at rest, during painful nerve stimulation, and while performing a memory task. The study aims to understand how remimazolam influences memory and pain perception. Participants will receive an intravenous infusion of remimazolam and painful electric nerve stimulation during MRI scans. The study involves imaging brain activity during no-drug and remimazolam conditions to compare effects on memory encoding and pain response. This single treatment arm includes monitoring functional connectivity and brain activation during these tasks. Participants will undergo MRI scans while receiving remimazolam and nerve stimulation, followed by assessments of explicit memory performance 12 to 36 hours after the first visit. Subjective pain ratings are collected immediately after MRI scans. The research team will measure brain imaging outcomes during both no-drug and drug conditions, with continuous monitoring of safety and responses throughout the study period.

CONDITIONS

Brief Title

Remimazolam NeuroImaging

Research Team

K

Keith M Vogt, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here